Johnson Shane Aaron has filed 3 insider transactions across 1 company since December 2023.
Most recent transaction: a grant/award of 8500 shares of InMed Pharmaceuticals Inc. ($INM) on December 19, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 19, 2025 | InMed Pharmaceuticals Inc. | $INM | Johnson Shane Aaron | Sr VP & General Manager | A | Employee Stock Option (Right to Buy) | 8500 | $0.00 | 12,400.0000 | 3,954,549 | 217.95% | 0.21% |
| Dec. 20, 2024 | InMed Pharmaceuticals Inc. | $INM | Johnson Shane Aaron | Sr VP & General Manager | A | Employee Stock Option (Right to Buy) | 1500 | $0.00 | 3,900.0000 | 620,127 | 62.50% | 0.24% |
| Dec. 23, 2023 | InMed Pharmaceuticals Inc. | $INM | Johnson Shane Aaron | Sr VP & General Manager | A | Employee Stock Option (Right to Buy) | 40000 | $0.00 | 48,000.0000 | 166,410 | 500.00% | 24.04% |